Everyone’s MPN Is Different: What You Should Know About Genetic Mutations

Published on

Topics include: Patient Stories and Treatments

Should you get a genetic test? Myeloproliferative neoplasm (MPN) experts, Dr. Alison Moliterno and Dr. Stephen Oh, help patients understand the driver mutations associated with MPNs such as JAK2V617F, calreticulin (CALR), MPL and others.  The experts explain why you should know your genetic mutations and how this knowledge can impact your care and treatment. The panel also discusses if MPNs are hereditary and what causes mutations. You’ll also hear from Marsha, a patient advocate, as she shares her own story.

The Living Well series is a Patient Empowerment Network program produced by Patient Power. We thank Incyte Corporation for their support. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring , and

Related Programs

Does Risk of Progression Increase If Essential Thrombocythemia (ET) Is Untreated?

In this Ask the Expert segment featuring Dr. Srdan Verstovsek, he responds to a community member who wants to know if the rate of progression is increased when essential thrombocythemia (ET) is left untreated.


How Can I Combat Depression Associated With Interferon Therapy?

Patient Power community member, Kathy, asks Dr. John Mascarenhas about the connection between depression and interferon therapy and how the condition can be managed.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on October 9, 2018